Myocardial infarction - Nursing Case Study

Pathophysiology

• Primary mechanism: Myocardial infarction is primarily caused by the rupture of an atherosclerotic plaque in a coronary artery, leading to thrombus (blood clot) formation, which obstructs blood flow and reduces oxygen supply to heart muscle tissue.

• Secondary mechanism: The reduced oxygen supply causes ischemia, resulting in myocardial cell death (necrosis) if blood flow is not restored promptly, leading to impaired heart function.

• Key complication: The necrosis and subsequent inflammatory response can lead to complications such as arrhythmias, heart failure, or ventricular wall rupture, necessitating timely medical intervention to minimize damage.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, nausea, diaphoresis, lightheadedness

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

As the medical team continued to monitor the 58-year-old male patient, his condition showed signs of deterioration. Approximately two hours after admission, the patient exhibited an increase in his respiratory distress. Oxygen saturation levels dropped further to 88% on room air, prompting the decision to initiate supplemental oxygen therapy via nasal cannula, which improved saturation to 94%. Despite this intervention, the patient reported increasing fatigue and his chest pain persisted, now described as an 8 out of 10 in intensity.

New diagnostic results revealed elevated cardiac biomarkers, with a troponin I level of 8 ng/mL, indicating significant myocardial injury. An electrocardiogram (ECG) confirmed ST-segment elevation in the anterior leads, consistent with an evolving anterior myocardial infarction. In addition, a bedside echocardiogram showed decreased left ventricular ejection fraction at 40%, suggesting impaired cardiac output and early signs of heart failure.

These findings prompted the healthcare team to escalate care. A decision was made to initiate intravenous nitroglycerin to manage the patient's chest pain and reduce cardiac workload. Concurrently, preparations for percutaneous coronary intervention (PCI) were expedited to restore coronary blood flow. The possibility of developing complications such as cardiogenic shock or arrhythmias was discussed, emphasizing the need for continuous cardiac monitoring and readiness to respond to any acute changes in the patient's status. This critical juncture in the patient's care required vigilant assessment and prompt intervention to mitigate further myocardial damage and prevent life-threatening sequelae.

Section 2

As the medical team continued to monitor the patient's response to the initiated interventions, attention was focused on his vital signs and overall stability. Approximately one hour after starting the intravenous nitroglycerin infusion, the patient's blood pressure began to trend downward, with readings showing a mild hypotensive state at 94/56 mmHg. While the chest pain decreased slightly to a 6 out of 10, the patient now exhibited signs of increased restlessness and anxiety. This change in his presentation prompted a reassessment of his pain management and hemodynamic status.

A repeat ECG showed no significant changes in the ST-segment elevation pattern, but continuous cardiac monitoring revealed occasional premature ventricular contractions (PVCs), raising concerns about the potential for developing more severe arrhythmias. Despite these new findings, the patient's heart rate remained stable at 92 beats per minute. Given the hypotension and the risk of further cardiac complications, the healthcare team decided to adjust the nitroglycerin dose cautiously, balancing pain relief with maintaining adequate blood pressure.

In light of the potential for cardiogenic shock, additional laboratory tests were ordered to assess the patient's renal function and electrolyte status, which could further influence cardiac stability and the effectiveness of the interventions. The results indicated a mild elevation in serum creatinine at 1.8 mg/dL and a potassium level of 4.7 mEq/L, which were closely monitored to prevent exacerbation of cardiac issues. The medical team remained vigilant, prepared to initiate further advanced cardiac life support measures if the patient's condition continued to deteriorate. This ongoing scenario underscored the complexity of managing acute myocardial infarction with evolving complications, highlighting the importance of timely diagnostic evaluation and careful adjustment of therapeutic strategies.

Section 3

As the medical team continued to monitor the patient's evolving condition, a change in his status became increasingly evident. Despite the cautious adjustment of the nitroglycerin infusion, the patient's blood pressure further declined to 88/54 mmHg, prompting concerns about inadequate perfusion to vital organs. The patient's restlessness and anxiety persisted, accompanied by new symptoms of mild confusion and a cold, clammy skin texture, suggesting the early stages of cardiogenic shock. In response, the clinical team re-evaluated the patient's fluid status and considered the need for vasopressor support to stabilize his hemodynamics.

Concurrently, the laboratory results revealed a concerning trend: the patient's serum lactate levels had risen to 3.2 mmol/L, indicating potential tissue hypoperfusion and hypoxia. This finding emphasized the urgency of optimizing the patient's circulatory support to prevent further organ dysfunction. Given the mild elevation in serum creatinine, careful attention was also paid to fluid management to avoid exacerbating renal impairment. The healthcare team initiated a low-dose norepinephrine infusion to counteract the hypotension while closely monitoring the patient's urine output and renal function markers.

With the introduction of norepinephrine, the patient's blood pressure began to stabilize, registering at 102/60 mmHg. However, the premature ventricular contractions persisted, necessitating ongoing cardiac monitoring to detect any progression to more severe arrhythmias. The medical team prepared for possible antiarrhythmic intervention while continuing to assess the patient's response to the adjusted treatment plan. This delicate balance of managing myocardial infarction with emerging complications highlighted the importance of continuous evaluation and adaptation of therapeutic strategies, ensuring the patient's journey through this critical phase was navigated with precision and care.

Section 4

As the medical team continued to monitor the patient's response to the ongoing interventions, new diagnostic results indicated further complications developing in the patient's condition. The echocardiogram revealed a reduced ejection fraction of 35%, suggesting significant left ventricular dysfunction, which was likely contributing to the patient's hemodynamic instability. Additionally, troponin levels remained elevated, reflecting ongoing myocardial injury. These findings necessitated an urgent reassessment of the patient's medication regimen and the potential need for additional pharmacological support to improve cardiac output.

Concurrently, arterial blood gas analysis showed a mixed metabolic and respiratory acidosis, with a pH of 7.28, PaCO2 of 50 mmHg, and HCO3 of 18 mEq/L. This deterioration in acid-base balance indicated inadequate respiratory compensation for metabolic derangements, likely secondary to the cardiogenic shock and reduced tissue perfusion. The patient's oxygen saturation dropped to 90% on a 50% venturi mask, prompting the team to consider non-invasive ventilation to improve oxygenation and reduce the work of breathing.

The evolving picture of left ventricular failure, compounded by the acid-base imbalance and hypoxemia, required a careful reassessment of the management plan. The clinical team deliberated on the introduction of an inotropic agent, such as dobutamine, to enhance cardiac contractility and optimize tissue perfusion. This strategic adjustment aimed to stabilize the patient's status, reduce myocardial oxygen demand, and prevent further multisystem complications. The team's ability to integrate these findings into a coherent plan of care underscored the importance of dynamic clinical reasoning in managing complex cases of myocardial infarction with evolving complications.

Section 5

As the clinical team implemented the adjusted management plan, including the initiation of dobutamine, the patient's hemodynamic status showed initial signs of improvement. Over the next few hours, continuous monitoring revealed a gradual increase in blood pressure, with readings stabilizing around 110/70 mmHg, and heart rate trending towards a more controlled rate of 90 beats per minute. However, despite these improvements in circulation, the patient's respiratory status remained a concern. The arterial blood gas analysis, repeated after the introduction of non-invasive ventilation, showed only slight improvement in the acid-base disturbance, with a pH of 7.30, PaCO2 of 48 mmHg, and HCO3 of 19 mEq/L. Oxygen saturation improved marginally to 92%, indicating partial effectiveness of the respiratory support.

In light of the persistent respiratory challenges, the team explored other potential causes for the inadequate gas exchange. A repeat chest X-ray was ordered and revealed new bilateral infiltrates, suggesting the development of pulmonary edema, likely secondary to the ongoing left ventricular failure. This finding required a reevaluation of fluid management strategies, with a shift towards more aggressive diuresis to alleviate the volume overload contributing to respiratory compromise. The decision to administer intravenous furosemide was made to enhance diuresis and reduce pulmonary congestion, with the expectation that these measures would further support respiratory function and improve overall oxygenation.

As the patient’s journey continued, vigilance was necessary to assess the response to these interventions and anticipate any additional complications that might arise. The clinical team remained alert to the potential for renal impairment due to enhanced diuresis and was prepared to adjust the treatment plan accordingly. This phase of management highlighted the critical importance of integrated clinical reasoning, as the team balanced interventions aimed at optimizing cardiac output, managing fluid balance, and ensuring adequate oxygenation to stabilize the patient’s condition and mitigate further risks.